文献速递肝病

肠源性内毒素与门窦血管性疾病伴门静脉高压的关联

Association between gut-derived endotoxins and porto-sinusoidal vascular disorder with portal hypertension.
PubMed 文献 · Aliment Pharmacol Ther · 2023-09-20

研究纳入33例活检证实的门窦血管性疾病(PSVD)伴门静脉高压患者和33名健康对照,检测肠道通透性标志物、血小板聚集/促凝标志物及肝组织免疫组化。PSVD患者脂多糖、连蛋白、血管性血友病因子、因子VIII、sP-选择素和F1+2升高,ADAMTS13降低;肝组织脂多糖定位、TLR4阳性巨噬细胞和血小板增多,TLR4阳性巨噬细胞数与门静脉炎症和纤维化相关。作者认为脂多糖-TLR4通路可能参与PSVD伴门静脉高压的病理生理基础。

要点

  • PSVD伴门静脉高压患者脂多糖、连蛋白、血管性血友病因子、因子VIII、sP-选择素和F1+2较健康对照升高,ADAMTS13降低。
  • PSVD肝组织中脂多糖定位、TLR4阳性巨噬细胞和血小板数量较健康供肝增多,TLR4阳性巨噬细胞数与门静脉炎症和纤维化相关。
  • 血清脂多糖与连蛋白、sP-选择素、因子VIII和血管性血友病因子相关。

核心结论

  • PSVD患者存在肠道通透性改变和内毒素血症,并与促聚集/促凝状态相关;组织学上PSVD与TLR4阳性细胞参与增多及肝窦内血小板聚集相关。
  • 作者认为脂多糖-TLR4通路可能参与PSVD伴门静脉高压的病理生理基础。

研究设计与样本

  • 研究纳入33例活检证实的PSVD伴门静脉高压患者和33名健康对照,进行静脉血采样检测肠道通透性、血小板聚集/微血管炎症和促凝标志物。
  • 对17例PSVD患者的肝活检组织进行组织形态学和免疫组化研究。

主要发现

  • 与健康对照相比,PSVD患者脂多糖、连蛋白、血管性血友病因子、因子VIII、sP-选择素和F1+2水平升高,ADAMTS13降低。
  • 血清脂多糖与连蛋白、sP-选择素、因子VIII和血管性血友病因子相关。
  • 组织学分析显示,与健康供肝样本相比,PSVD标本脂多糖定位增多、TLR4阳性巨噬细胞和血小板数量增多。
  • TLR4阳性巨噬细胞数量与门静脉炎症和纤维化相关;观察到肝窦扩张和毛细血管化。
  • PSVD活检显示胆管损伤迹象和胆管反应减少,Sox9阳性细胞群无改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Porto-sinusoidal vascular disorder (PSVD) is characterised by lesions involving portal veins and sinusoids in absence of cirrhosis with an unclear pathophysiology. However, its association with immunodeficiency, bowel disorders and abdominal bacterial infections supports the role of altered intestinal permeability and gut-derived endotoxins. The study aimed at assessing the association between serological markers of increased intestinal permeability, pro-aggregating/procoagulant state and liver injury in PSVD and portal hypertension. METHODS: Thirty-three patients with biopsy-proven PSVD and portal hypertension and 33 healthy subjects were submitted to a venous blood sampling for the measurement of zonulin and lipopolysaccharides (LPS) as markers of intestinal permeability, of s-Glycoprotein VI, sP-selectin, ADAMTS13 and von Willebrand factor (vWF), as markers of platelet aggregation and microvascular inflammation, factor VIII and F1 + 2 as markers of hypercoagulability. In 17 PSVD patients, histomorphological and immunohistochemical study on liver biopsies was performed. RESULTS: Compared with controls, PSVD patients had higher levels of LPS, zonulin, vWF, factor VIII and sP-selectin, F1 + 2. ADAMTS13 was reduced. Serum LPS correlated with zonulin, sP-selectin, FVIII and vWF. At histological analysis, PSVD specimens had increased LPS localisation, toll-like receptor-4(TLR4)-positive macrophages and platelet number compared with samples from healthy liver donors. TLR4+ macrophage number correlated with portal inflammation and fibrosis. Sinusoid dilation and capillarisation were observed. PSVD biopsies showed signs of biliary damage and reduced ductular reaction without alteration in Sox9+ cell population. CONCLUSIONS: PSVD patients display an altered intestinal permeability and endotoxemia correlated to a pro-aggregating/procoagulant state; histologically, PSVD was associated with increased TLR4+ cell involvement and platelet clumps within sinusoids. Our study suggests that LPS-TLR4 pathway could contribute to the pathophysiological basis of PSVD with portal hypertension.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Gioia S, Carnevale R, Tavano D, et al. Association between gut-derived endotoxins and porto-sinusoidal vascular disorder with portal hypertension. Aliment Pharmacol Ther. 2023. PMID: 37728001. doi:10.1111/apt.17727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。